In 2025, the Moscow-based industrial holding company Evers Group Rus confirmed its leading position in medical technology, achieving significant success in the production of innovative products. The company produced approximately 60,000 wound dressings of various modifications, which have found widespread use in medical practice. These products boast advanced characteristics, demonstrating the company's high level of expertise and professionalism. Information about the holding's achievements was published on the official website of the Mayor of Moscow, underscoring the importance of this area for the development of the capital's industry and healthcare.
By the end of the year, the company plans to double its production volume, reflecting growing demand for its products and a high level of trust from the medical community.
The innovative chitosan-based Khitokol® product, developed by the company's specialists, deserves special attention. This product is intended for the treatment of complex wounds and significantly accelerates tissue regeneration. Its appearance on the market opens up new opportunities for effective therapy and improved quality of life for patients.
Such achievements confirm the high level of competence of Russian specialists and demonstrate the potential of the domestic industry in the field of high-tech developments. Evers Group Rus continues to grow rapidly, making a significant contribution to the development of the medical industry and strengthening Russia's position in the global market.